4.8 Editorial Material

Adverse effects of acquisitions in the pharmaceutical industry

Journal

NATURE MEDICINE
Volume 28, Issue 7, Pages 1342-1344

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41591-022-01784-5

Keywords

-

Funding

  1. Swiss National Science Foundation (SNSF)

Ask authors/readers for more resources

Publicly funded research contributes to the development of new drugs, but the profits are primarily obtained by big pharmaceutical companies through exclusive licensing deals, mergers, and acquisitions, which can lead to decreased competition and limited access to medicines for patients.
Publicly funded research leads to the development of many new drugs, but the profits are largely reaped by big pharmaceutical companies through exclusive licensing deals, mergers and acquisitions, which can reduce competition and patients' access to medicines.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available